Immediate Impact

2 from Science/Nature 54 standout
Sub-graph 1 of 25

Citing Papers

Pancreatic cancer
2025 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
2 intermediate papers

Works of Kaoru Takagi being referenced

The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer
2017
Smoking, Family History of Cancer, and Diabetes Mellitus Are Associated With the Age of Onset of Pancreatic Cancer in Japanese Patients
2014

Author Peers

Author Last Decade Papers Cites
Kaoru Takagi 177 172 115 39 479
Taoufik Najjar 197 75 59 59 500
Shlomo Shimonovitz 55 17 34 28 566
Rupal Sinha 113 178 61 32 519
Biren Parikh 196 260 129 33 555
Stefania Sorrentino 115 38 21 36 454
Maciej J. K. Simon 119 131 42 35 560
Yasuo Uesugi 116 61 84 47 571
Bradley El 295 138 75 27 483
J. Scott Nystrom 90 288 134 23 493
T. Genz 120 166 101 33 527

All Works

Loading papers...

Rankless by CCL
2026